Ivan Ahel

13.8k citations
155 papers · 11.3k · 2 hit papers · h-index 61

Impact in

  • Physiology top 0.2%
    • Calcium signaling and nucleotide metabolism
  • Oncology top 0.5%
    • PARP inhibition in cancer therapy

Papers in

    • PARP inhibition in cancer therapy 57
    • DNA Repair Mechanisms 40
    • Biochemical and Molecular Research 27
    • RNA and protein synthesis mechanisms 11
    • Ubiquitin and proteasome pathways 11

Ivan Ahel

149 papers receiving 11.2k citations

Ivan Ahel's Hit Papers

ADP-ribosylation from molecular mechanisms to therapeutic implications 2023 · 130 citations
1300+1+3Years since publication50100150200

Peers

Ivan Ahel
Comparison fields: 5 of 118
  • Physiology 995
  • Oncology 4.2k
  • Geriatrics and Gerontology 618
  • Molecular Biology 6.8k
  • Aging 67
Replace Andreas G. Ladurner with:
Andreas G. Ladurner Germany
Anthony K. L. Leung United States
Ivan Matić Germany
John M. Pascal United States
Peter K. Jackson United States
Martin Rechsteiner United States
Stephen Craig West United Kingdom
Klaus Scheffzek Germany
Maojun Yang China
Mark J. Skehel United Kingdom
Ivan Ahel relative to Andreas G. Ladurner Germany Andreas G. Ladurner's profile →
Citations per field
00.5×2×3×4.1×
Andreas G. Ladurner · 1×
Citations per year

Countries citing papers authored by Ivan Ahel

Since Specialization
Citations

This map shows the geographic impact of Ivan Ahel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Ahel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Ahel more than expected).

Fields of papers citing papers by Ivan Ahel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Ahel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Ahel. The network helps show where Ivan Ahel may publish in the future.

Co-authors

The 25 scholars most cited alongside Ivan Ahel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ivan Ahel Line = papers co-authored together Ivan Ahel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 155 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2009496
2 2014412
3 2003404
4 2008366
5 2006324
6 2011321
7 2007291
8 2017291
9 2013272
10 2016263
11
ADP‐ribosyltransferases, an update on function and nomenclature
Hit paper breakdown →
2021241
12 2020224
13 2015219
14 2016205
15 2018201
16 2017197
17 2016185
18 2016185
19 2003159
20 2016158

About Ivan Ahel

Ivan Ahel is a scholar working on Oncology, Molecular Biology, Physiology, Geriatrics and Gerontology and Infectious Diseases, having authored 155 papers that have together received 11.3k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (57 papers), DNA Repair Mechanisms (40 papers), Biochemical and Molecular Research (27 papers), Calcium signaling and nucleotide metabolism (20 papers), Enzyme Structure and Function (15 papers), Sirtuins and Resveratrol in Medicine (12 papers), RNA and protein synthesis mechanisms (11 papers) and Ubiquitin and proteasome pathways (11 papers). The work is most often cited by research in Physiology (995 citations), Oncology (4.2k citations), Geriatrics and Gerontology (618 citations), Molecular Biology (6.8k citations) and Aging (67 citations). Ivan Ahel has collaborated with scholars based in United Kingdom, United States and Croatia. Frequent co-authors include Stephen Craig West, J.G.M. Rack, Gytis Jankevicius, Ivan Matić, Luca Palazzo, Eva Barkauskaite, Dragana Ahel, Ulrich Rass, Andreja Mikoč and Roko Žaja. Their work appears in journals such as Molecular Cell, Nature Communications, Journal of Biological Chemistry, Nucleic Acids Research and Nature Structural & Molecular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact